Effect of a Laparoscopic Donor Nephrectomy in Healthy Living Kidney Donors on the Acute Phase Response Using Either Propofol or Sevoflurane Anesthesia
Brattinga B. et al, (2025), International Journal of Molecular Sciences, 26, 5196 - 5196
CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue.
Liu F. et al, (2025), Ann Rheum Dis
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Zwerwer LR. et al, (2025), Nat Commun, 16
EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis.
van Veggel L. et al, (2025), Biomed Pharmacother, 186
Integrative proximal-ubiquitomics profiling for deubiquitinase substrate discovery applied to USP30.
Damianou A. et al, (2025), Cell Chem Biol
Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma
Furqan M. et al, (2025), Pharmaceutics, 17, 549 - 549
Activity-based protein profiling reveals both canonical and novel ubiquitin pathway enzymes in Plasmodium
Smith C. et al, (2025), PLOS Pathogens, 21, e1013032 - e1013032
MolSnapper: Conditioning Diffusion for Structure-Based Drug Design.
Ziv Y. et al, (2025), J Chem Inf Model
Structure-Guided Design of ISOX-DUAL-Based Degraders Targeting BRD4 and CBP/EP300: A Case of Degrader Collapse.
Edmonds AK. et al, (2025), J Med Chem
Structures of the human adult muscle-type nicotinic receptor in resting and desensitized states.
Li A. et al, (2025), Cell Rep, 44
Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment.
Chen Z. et al, (2025), Nat Commun, 16
The ubiquitin E3 ligase Huwe1 facilitates viral and self RNA sensing by RIG-I-like receptors
Oosenbrug T. et al, (2025)
A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014-present).
Aiken SG. et al, (2025), Expert Opin Ther Pat, 1 - 11
Pharmacological targeting of BMAL1 modulates circadian and immune pathways.
Pu H. et al, (2025), Nat Chem Biol
Drug repurposing in amyotrophic lateral sclerosis (ALS).
Carroll E. et al, (2025), Expert Opin Drug Discov, 1 - 18